Mental Disorder Treatment Market Is Witnessing Strong Growth Due To Growing Awareness About Mental Health Across The Globe


Mental disorder treatment is a multi-step process that starts with patient’s medical exam and a psychological evaluation. A doctor may also perform blood work and imaging tests to rule out other causes of their symptoms, such as a physical illness. Medications can reduce symptoms and improve functioning in some people with certain disorders and conditions. These medications change chemicals in the brain to relieve symptoms and improve thinking. Some drugs are safe for long-term use, and others can have serious side effects.

Increasing number of individuals suffering from mental illnesses is expected to augment growth of the global mental disorder treatment market over the forecast period. People around the world are increasingly suffering from mental state disorders or mental disorders, due to which various public and government organizations are focused on raising public awareness regarding mental illnesses. For instance, as per the World Health Organization (WHO), one in every eight people or 970 million individuals across the globe suffered from a mental disorder during 2019, with depressive disorders and anxiety being the most common.

However, factors such as high cost of diagnosing and treating mental disorders are anticipated to impede growth of the global mental disorder treatment market over the forecast period. Moreover, reluctance among older population towards seeking treatment is also likely to hamper the market growth.

The global Mental Disorder Treatment Market is estimated to be valued at US$ 48.4 Billion in 2020 and is expected to exhibit a CAGR of 6.6% during the forecast period (2020-2027).

Impact of COVID-19:

The coronavirus outbreak positively affected the global mental disorder treatment market, as the number of people suffering from mental illnesses, stress and other mental state conditions increased during the pandemic, as a result of lockdown, where people had to stay inside their houses. According to the WHO, there was a significant increase around the world in the number of individuals living with depressive and anxiety disorder due to the Covid-19 in 2020. The demand for treatment, medicines for mental illnesses rapidly increased in pandemic. Thus, this in turn lucratively impacted the market.

Key Takeaways:

· The global mental disorder market to grow with a CAGR of XY% during the forecast period, due to rise in old age population and growing number of awareness programs about mental health. For instance, as per the World Bank data, the rate of geriatric populations increased globally from 9.102% in 2019 to 9.321% in 2020, which is 723,184,486.

· North America is projected to show robust growth in the global mental treatment market over the forecast period. This can be attributed to growing adoption of advanced technologies, along with rise in awareness about mental health in people working in the corporate industry and healthcare professionals across the region

· Key players operating in the global mental treatment market are Eli Lily and Company, Bristol-Myers Squibb Company, Forest Laboratories, Lundbeck A/S, AstraZeneca PLC, Johnson and Johnson, Sanofi-Aventis, GlaxoSmithKline PLC, Merck & Co., and Pfizer

Comments

Popular posts from this blog

Global Flocculant And Coagulant Market Is Estimated To Witness High Growth Owing To Increasing Demand For Water Treatment Applications

Linear Motion System Control Movements with Various Variables and Complication

Recent Advancement in Synthesis and Process Development Of Polyether Polyols